SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

JP Bayley, HPM Kunst, A Cascon, ML Sampietro, José Gaal, Esther Korpershoek, A Hinojar-Gutierrez, HJLM Timmers, LH Hoefsloot, MA Hermsen, C Suarez, AK Hussain, AHJT Vriends, FJ Hes, JC (Jeroen) Jansen, CM Tops, EP Corssmit, P de Knijff, JWM Lenders, CWRJ CremersP Devilee, Winand Dinjens, Ronald de Krijger, M Robledo

Research output: Contribution to journalArticleAcademicpeer-review

229 Citations (Scopus)

Abstract

Background Paragangliomas and phaeochromocytomas are neuroendocrine tumours associated frequently with germline mutations of SDHD, SDHC, and SDHB. Previous studies have shown the imprinted SDHAF2 gene to be mutated in a large Dutch kindred with paragangliomas. We aimed to identify SDHAF2 mutation carriers, assess the clinical genetic significance of SDHAF2, and describe the associated clinical phenotype. Methods We undertook a multicentre study in Spain and the Netherlands in 443 apparently sporadic patients with paragangliomas and phaeochromocytomas who did not have mutations in SDHD, SDHC, or SDHB. We analysed DNA of 315 patients for germline mutations of SDHAF2; a subset (n=200) was investigated for gross gene deletions. DNA from a group of 128 tumours was studied for somatic mutations. We also examined a Spanish family with head and neck paragangliomas with a young age of onset for the presence of SDHAF2 mutations, undertook haplotype analysis in this kindred, and assessed their clinical phenotype. Findings We did not identify any germline or somatic mutations of SDHAF2, and no gross gene deletions were noted in the subset of apparently sporadic patients analysed. Investigation of the Spanish family identified a pathogenic germline DNA mutation of SDHAF2, 232G -> A (Gly78Arg), identical to the Dutch kindred. Interpretation SDHAF2 mutations do not have an important role in phaeochromocytoma and are rare in head and neck paraganglioma. Identification of a second family with the Gly78Arg mutation suggests that this is a crucial residue for the function of SDHAF2. We conclude that SDHAF2 mutation analysis is justified in very young patients with isolated head and neck paraganglioma without mutations in SDHD, SDHC, or SDHB, and in individuals with familial antecedents who are negative for mutations in all other risk genes.
Original languageUndefined/Unknown
Pages (from-to)366-372
Number of pages7
JournalLancet Oncology
Volume11
Issue number4
Publication statusPublished - 2010

Cite this